FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Pulmonary Stent
PMA: P220004
·
Supplement: S002
·
Decision Sep 5, 2024
Classifications
1
FEI Numbers
2
Registration Numbers
2
Basic Information
- Device Name
- Pulmonary Stent
- Trade Name
- PALMAZ MULLINS XD Pulmonary Stent
- PMA Number
- P220004
- Supplement Number
- S002
- Device Class
- FDA Class 3
- Product Code
- QWC
- Generic Name
- Pulmonary stent
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- September 5, 2024
- Date Received
- August 6, 2024
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
an updated packaging configuration without physical Instructions for Use
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| QWC | Pulmonary Stent | FDA class 3 | Unknown |